
Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China: management transactions · Italy · Consob
CONSOB:pharmanutra-pharmanutra-spa-first-significant-sales-results-in-chinaITIT·ConsobMcap 862M€Healthcare
Browse the full directors' dealings record of Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China, a listed equity based in Italy. Shares are quoted on IT IT, under the supervision of Consob. Operating in the Healthcare sector, Pharmanutra Pharmanutra S.p.a.: First Significant Sales Results in China has published 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was filed on 18 November 2024 — Other. Among the most active insiders: Unknown. Every trade is openly available.
Financial data
FY ended December 2025 · cache
Analyst consensus
3 analysts76.00 €Target 81.33 €(-10%)86.00 €
Income statement
Revenue132.9 M€
Gross profit102.9 M€77% margin
Net income20.0 M€15.2% margin
Valuation
PER (trailing)40.9x
PER (forward)29.4x
P/Book12.1x
Balance sheet & cash
Market cap861.8 M€
Total debt20.5 M€
Free Cash Flow16.4 M€
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.1%
% insiders65.0%
% institutions16.1%
Last declaration on 18 November 2024